Adults 50 to 70, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change From Baseline Energy Expenditure (Measured in METs Using the BACPR Conversion Chart) and After 8 Weeks of Intervention.Primary· The Walk Test will be completed pre and post intervention (8 weeks apart)
An Incremental Shuttle Walk test will be performed to determine the Metabolic equivalent achieved at each level. Metabolic Equivalent (1 MET) is defined as the amount of energy required to serve the body's energy needs. This will range from 1 METs = lowest energy requirement to 10.9 METs highest energy requirement for completing the test. Walking at a slower pace requires a lower level of energy expenditure and is therefore considered a light-intensity activity, walking at a faster pace requires a higher energy expenditure and is therefore considered a higher-intensity activity. The higher the
Pre intervention
Group
Value
95% CI
Traditional Cardiac Rehabilitation (Hospital Based Programme)
5.9
5.5 – 6.4
Traditional Combined With Web-based Cardiac Rehabilitation
5.8
5.4 – 6.2
Web-based Cardiac Rehabilitation
5.6
5.2 – 6.0
Post Intervention
Group
Value
95% CI
Traditional Cardiac Rehabilitation (Hospital Based Programme)
7.4
6.9 – 7.9
Traditional Combined With Web-based Cardiac Rehabilitation
7.3
6.9 – 7.7
Web-based Cardiac Rehabilitation
6.5
6.1 – 7.0
Psychological Outcome - Hospital Anxiety and Depression Score Pre and Post InterventionSecondary· Questionnaires will be given to the patient to complete pre and post intervention. (8 weeks apart)
This will be evaluated through participants completing a Hospital Anxiety and Depression questionnaire. Scoring range: 0-7 = normal range, 8-10 = borderline abnormal,11-21 abnormal and treatment is indicated. The questionnaire comprises of 7 questions for Anxiety and 7 for Depression with a total score for each ranging from 1-21. The scores will be reported separately for Anxiety and depression. The higher the score the worse the outcome for the participant as this indicates a higher level of either anxiety or depression.
Pre Intervention (Anxiety Score)
Group
Value
95% CI
Traditional Cardiac Rehabilitation (Hospital Based Programme)
4.95
± 3.1
Traditional Combined With Web-based Cardiac Rehabilitation
4.56
± 3.05
Web-based Cardiac Rehabilitation
5.65
± 3.25
Post Intervention (Anxiety Score)
Group
Value
95% CI
Traditional Cardiac Rehabilitation (Hospital Based Programme)
3.68
± 2.45
Traditional Combined With Web-based Cardiac Rehabilitation
4.00
± 3.77
Web-based Cardiac Rehabilitation
4.53
± 2.98
Pre Intervention (Depression Score)
Group
Value
95% CI
Traditional Cardiac Rehabilitation (Hospital Based Programme)
4.53
± 3.58
Traditional Combined With Web-based Cardiac Rehabilitation
3.28
± 2.42
Web-based Cardiac Rehabilitation
4.59
± 3.22
Post Intervention (Depression Score)
Group
Value
95% CI
Traditional Cardiac Rehabilitation (Hospital Based Programme)
3.16
± 2.47
Traditional Combined With Web-based Cardiac Rehabilitation
2.44
± 2.09
Web-based Cardiac Rehabilitation
3.94
± 3.03
Psychological Status at Baseline (Using the Dartmouth Coop Questionnaire) and After 8 Weeks of Intervention.Secondary· Questionnaires will be given to the patient to complete pre and post intervention. (8 weeks apart)
This will be evaluated through participants completing a questionnaire consisting of questions measuring health status, physical fitness, feelings, daily activities, social activities, change in health status, current overall health perceptions and bodily pain. Each question gives 5 response options, 1= very good, 2= good, 3= Moderate, 4=Bad, 5= Very Bad. Minimum score = 9, maximum score 45. Total score gives a profile of health status i.e, higher total score = poor health status. The scores will be evaluated at baseline and after 8 weeks of intervention. The score should be lower after 8 week
Pre Intervention
Group
Value
95% CI
Traditional Cardiac Rehabilitation (Hospital Based Programme)
21.9
± 5.63
Traditional Combined With Web-based Cardiac Rehabilitation
20.1
± 5.01
Web-based Cardiac Rehabilitation
21.35
± 5.38
Post Intervention
Group
Value
95% CI
Traditional Cardiac Rehabilitation (Hospital Based Programme)
16.4
± 3.57
Traditional Combined With Web-based Cardiac Rehabilitation
15.7
± 2.63
Web-based Cardiac Rehabilitation
17.41
± 4.50
Heart Rate Walking Speed Index at Baseline and After 8 Weeks of InterventionSecondary· The Walk Test will be completed pre and post intervention (8 weeks apart)
An Incremental Shuttle Walk test will be performed to evaluate functional capacity and determine what percentage of predicted heart rate the participant has achieved at each level of the walk test. The maximum Heart Rate achieved at the end of the walk test will then be converted to walking speed index (HRWSI). This will be converted using the BACPR HRWSI table which looks at the number of heart beats for every 10 meters walked when completing a standardised walking test. HRWSI is calculated by dividing Heart rate by the walking speed (meters per minute) multiplied by 10 to give heart beats pe
Pre Intervention
Group
Value
95% CI
Traditional Cardiac Rehabilitation (Hospital Based Programme)
11.3
10.2 – 12.5
Traditional Combined With Web-based Cardiac Rehabilitation
11.3
10.5 – 12.1
Web-based Cardiac Rehabilitation
12.2
11.1 – 13.3
Post Intervention
Group
Value
95% CI
Traditional Cardiac Rehabilitation (Hospital Based Programme)
10.2
9.3 – 11.1
Traditional Combined With Web-based Cardiac Rehabilitation
10.2
9.6 – 10.8
Web-based Cardiac Rehabilitation
10.9
9.8 – 12.2
Sponsor's own description
The study explores the different modes of Cardiac Rehabilitation delivery including the use of a web-based programme. Cardiac Rehabilitation provides a structured, comprehensive programme, proven to reduce cardiovascular mortality and improve overall Quality of Life. However, as uptake remains relatively low with only 50% attending, exploring the benefits of offering a menu of programme options may allow greater patient choice and accessibility, meeting individual needs.
This study aims to compare how effective Cardiac Rehabilitation Programmes are on improving cardiovascular patients physical and mental wellbeing using a web-based compared with traditional cardiac rehab programmes in the hospital or through a combination of both.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Other recruiting trials for Cardiovascular Diseases
Currently open trials in the same condition.
NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial
· NA
· active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation.
· NA
· active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO
· NA
· recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming
· NA
· recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under
· NA
· recruiting
Other University of Chester trials
Trials by the same sponsor.
NCT05764473 — Diet, Cardiometabolic Risk (CM) and Menopause Symptoms
· NA
· completed
NCT04117581 — A Study to Investigate the Effect of Vitamin D3 Supplementation on Asthma Symptoms in Adults With Asthma (VITDAS)
· NA
· completed
NCT03553784 — Low-Intensity CBT for Gynaecological Cancer Survivors
· NA
· completed
NCT03961763 — Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins
· NA
· completed
NCT04641494 — The Effect of CLA on Obesity, Lung Functions, Lipid Profile and Inflammation in Women With BMI≥25
· NA
· completed
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Chester
Last refreshed: 28 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05326529.